10Apr 2018

CORRELATIVE STUDY BETWEEN LIPID PROFILE AND DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS ? A HOSPITAL BASED STUDY.

Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Objective: To study the serum lipid profile, disease activity and their correlation in patients with Rheumatoid Arthritis. Materials and methods: The study was carried out on 50 diagnosed patients of RA in the Department of Biochemistry, Assam Medical College and hospital, Dibrugarh. 50 apparently age and sex matched individuals were taken as controls. Fasting lipid profile (Total cholesterol, HDL-c, LDL-c, Triglyceride) was estimated in semiautoanalyser using standard method. Disease activity was assessed by DAS28 ESR score. Results: Serum total cholesterol (TC) and HDL-c were significantly lower in cases than controls (p<0.05 and p<0.01 respectively). Patients with active disease had significantly lower level of TC and HDL -c than those in remission. Triglyceride levels was significantly higher in cases than controls (p<0.05). Conclusion: Study reveals that the lipid profile is altered in Rheumatoid arthritis characterized by low TC, HDL and elevated triglycerides. Further in active cases the mean serum level of total cholesterol and HDL cholesterol were significantly lower than cases in remission. A significant negative correlation was seen between HDLc and DAS28.

  1. Longo DL,Kasper DL,Jameson JL,Fauci AS,Hauser SL, Loscalzo J,Eds. Harrison?s Principle of Internal Medicine,18th United States of America: McGraw Hill; 2012:2738-2751.
  2. Hadda V,Handa R, Aggarwal P, Lakshmy R, Kumar U, Pandey RM.Disease activity and lipids in RA : A prospective study. Indian Journal of Rheumatology 2007; 2(4): 137-140.
  3. Toms TE, Panoulas VF and Kitas GD.Dyslipidemia in rheumatological autoimmune disease. Open Cardiovascular Med J 2011;5:64-75.
  4. Popa CD, Arts E,? Fransen J, and? van Riel PL. Atherogenic Index and High-Density Lipoprotein Cholesterol as Cardiovascular Risk Determinants in Rheumatoid Arthritis:The Impact of Therapy with Biologicals . Mediators of? 2012; 2012:785946. Epub 2012.
  5. Vinapamula KS , Manohar SM ,? Bitla AR et al. Evaluation of dyslipidaemia in patients with rheumatoid arthritis in South Indian population. Indian journal of rheumatology 2013; 8:155-160.
  6. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO et al. 2010 Rheumatoid Arthritis Classification Criteria An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative. Arthritis & Rheumatism. 2010;62(9):2569?2581.
  7. Felson DT, Smolen JS,? Wells G et al. American College of Rheumatology/European League against Rheumatism Preliminary Definition of Remission in Rheumatoid Arthritis for Clinical Trials. Arthritis Rheum. Mar 2011; 63(3): 573?586.
  8. Singh JA, Furst DE,Bharat A, Curtis JR,Kavanaugh AF,Kremer JM et al. 2012 Update of the 2008 American College of Rheumatology Recommendations for the Use of Disease-Modifying Antirheumatic Drugs and Biologic Agents in the Treatment of Rheumatoid Arthritis. Arthritis Care & Research 2012; 64(5):625-639.
  9. Vaunkumar D, Prasad BVM, Vishwanth HL. Study of Lipid Profile and High Sensitivity C - reactive protein as Prognostic Indicators of Cardiovascular Risk in Rheumatoid Arthritis: A Prospective Study. RJPBCS 2013; 4(2):1242-1250.
  10. Dessein PH, Stanwix AE, Joffe BI. Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis. Arthritis Res 2002, 4:R5.
  11. Georgiadis AN, Papavasiliou EC, Lourida ES, et al. Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment-a prospective controlled study. Arthritis Res Ther. 2006; 8:R82.
  12. Borman P, Seckin ?mit , Yucel Metin .Dyslipidemia in patients with rheumatoid arthritis and osteoarthritis. Physical Medicine 1999; 2 (3) : 5-9.
  13. Vottery R, Saigal R, Singhal N, Gupta BS. Lipid profile in rheumatoid arthritis and its relation to disease activity. J Assoc Physicians India. 2001;49:1188-90.
  14. Lazarevic MB,?Vitic J,?Mladenovic V,?Myones BL,?Skosey JL,?Swedler WI. Dyslipoproteinemia in the course of active rheumatoid arthritis. Semin Arthritis Rheum.1992 Dec;22(3):172-8.
  15. Svenson KLG, Lithell H,?? H?llgren R,?? Selinus I,?? Vessby B. Serum Lipoprotein in Active Rheumatoid Arthritis and Other Chronic Inflammatory Arthritides Relativity to Inflammatory Activity. Arch Intern Med.?1987;147(11):1912-1916.
  16. Kim SH,Lee CK,?Lee EY,?Park SY,?Cho YS,?Yoo B et al. Serum oxidized low-density lipoproteins in rheumatoid arthritis. Rheumatol Int.?2004 Jul; 24(4):230-3.
  17. Nassir SF, Ewadh RS, Jasim ZM, Anoze A. Serum Lipid Profile in Early Rheumatoid Arthritis. Medical Journal of Babylon ? 2007 Volume 4 No .3 and No. 4.
  18. Kowsalya R, Sreekantha, Chandran V, Remya. Dyslipidemia with altered oxidant -antioxidant status in rheumatoid arthritis. Int J Pharm Biosci. 2011;2:B424-B428.
  19. Mahdi EA, Mohamed LA, Hadi The Relationship between Lipid Profile and Inflammatory Markers in Patients with Early Rheumatoid Arthritis. Iraqi National Journal of Chemistry.2012; 47:391-400.\\
  20. Lakatos J, Harsagyi A. Serum total, HDL, LDL cholesterol, and triglyceride levels in patients with rheumatoid arthritis. Clin Biochem1988;21(2):93-96.
  21. Boers M, Nurmohamed MT,? Doelman CJA ,Lard LR, Verhoeven AC,Voskuyl AE et al. Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis. Ann Rheum Dis 2003; 62:842?845.
  22. Mullick OS, Bhattacharya R , Bhattacharyya K, Sarkar RN, Das A,Chakraborty D et al. Lipid profile and its relationship with endothelial dysfunction and disease activity in patients of early Rheumatoid Arthritis. Indian journal of rheumatology 2014;9:9-13.
  23. Choy E, Ganeshalingam K, Semb AG, Zolta? n Szekanecz, Nurmohamed M. Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment. J Rheumatol 2014.
  24. Hashizume M, Mihara M. The Roles of Interleukin-6 in the Pathogenesis of Rheumatoid Arthritis. Arthritis 2011.
  25. Steiner G, Urowitz MB. Lipid Profiles in Patients with Rheumatoid Arthritis:Mechanisms and the Impact of Treatment. Semin Arthritis Rheum 2009;38:372-381.
  26. Sattar N, McCarey DW, Capell H,McInnes IB.Explaining How \'\'High-Grade\'\' Systemic Inflammation Accelerates Vascular Risk in Rheumatoid Arthritis. ?2003; 108:2957?2963.

[Sushma Yadav, R. K. Goswami and Girindra Kumar Bora. (2018); CORRELATIVE STUDY BETWEEN LIPID PROFILE AND DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS ? A HOSPITAL BASED STUDY. Int. J. of Adv. Res. 6 (Apr). 625-632] (ISSN 2320-5407). www.journalijar.com

DR GIRINDRA KUMAR BORA
Research Officer( MD , BIOCHEMISTRY), RARI FOR GID, GUWAHATI

DOI:

Article DOI: 10.21474/IJAR01/6896      
DOI URL: https://dx.doi.org/10.21474/IJAR01/6896

Download Full Paper

Download PDF No. of Downloads: 69 | No. of Views: 235